现代肿瘤医学
現代腫瘤醫學
현대종류의학
JOURNAL OF MODERN ONCOLOGY
2014年
5期
1076-1078
,共3页
三阴乳腺癌%吉西他滨%卡铂%顺铂
三陰乳腺癌%吉西他濱%卡鉑%順鉑
삼음유선암%길서타빈%잡박%순박
triPle - negative breast cancer%gemcitabine%carboPlatin%cisPlatin
目的:比较吉西他滨联合卡铂(GC)方案与吉西他滨联合顺铂(GP)方案治疗晚期三阴乳腺癌的疗效及毒副反应。方法:将57例蒽环类及紫杉类耐药的晚期三阴乳腺癌患者分为 GC 组(29例)和 GP 组(28例),观察两组的疗效及毒副反应。结果:GC 组和 GP 组的有效率分别为62.1%和57.1%(P ﹥0.05);两组的中位肿瘤进展时间(TTP)分别为5.4个月和5.6个月,中位生存期分别为8.3个月和9.0个月,均无显著性差异(P ﹥0.05)。GC 组的Ⅲ-Ⅳ度胃肠道反应发生率(6.9%)明显低于 GP 组(28.6%)(P ﹤0.05),而 GC组Ⅲ-Ⅳ度粒细胞减少率(31.0%)较 GP 组(14.3%)明显升高(P ﹤0.05)。结论:吉西他滨联合卡铂方案二线治疗晚期三阴乳腺癌疗效肯定,较吉西他滨联合顺铂有效率相似,GC 方案治疗组Ⅲ/Ⅳ度中性粒细胞减少症发生率高,GP 方案治疗组Ⅲ/Ⅳ度胃肠道反应发生率高,在临床使用方面可以根据患者的特点选择具体的治疗方案。
目的:比較吉西他濱聯閤卡鉑(GC)方案與吉西他濱聯閤順鉑(GP)方案治療晚期三陰乳腺癌的療效及毒副反應。方法:將57例蒽環類及紫杉類耐藥的晚期三陰乳腺癌患者分為 GC 組(29例)和 GP 組(28例),觀察兩組的療效及毒副反應。結果:GC 組和 GP 組的有效率分彆為62.1%和57.1%(P ﹥0.05);兩組的中位腫瘤進展時間(TTP)分彆為5.4箇月和5.6箇月,中位生存期分彆為8.3箇月和9.0箇月,均無顯著性差異(P ﹥0.05)。GC 組的Ⅲ-Ⅳ度胃腸道反應髮生率(6.9%)明顯低于 GP 組(28.6%)(P ﹤0.05),而 GC組Ⅲ-Ⅳ度粒細胞減少率(31.0%)較 GP 組(14.3%)明顯升高(P ﹤0.05)。結論:吉西他濱聯閤卡鉑方案二線治療晚期三陰乳腺癌療效肯定,較吉西他濱聯閤順鉑有效率相似,GC 方案治療組Ⅲ/Ⅳ度中性粒細胞減少癥髮生率高,GP 方案治療組Ⅲ/Ⅳ度胃腸道反應髮生率高,在臨床使用方麵可以根據患者的特點選擇具體的治療方案。
목적:비교길서타빈연합잡박(GC)방안여길서타빈연합순박(GP)방안치료만기삼음유선암적료효급독부반응。방법:장57례은배류급자삼류내약적만기삼음유선암환자분위 GC 조(29례)화 GP 조(28례),관찰량조적료효급독부반응。결과:GC 조화 GP 조적유효솔분별위62.1%화57.1%(P ﹥0.05);량조적중위종류진전시간(TTP)분별위5.4개월화5.6개월,중위생존기분별위8.3개월화9.0개월,균무현저성차이(P ﹥0.05)。GC 조적Ⅲ-Ⅳ도위장도반응발생솔(6.9%)명현저우 GP 조(28.6%)(P ﹤0.05),이 GC조Ⅲ-Ⅳ도립세포감소솔(31.0%)교 GP 조(14.3%)명현승고(P ﹤0.05)。결론:길서타빈연합잡박방안이선치료만기삼음유선암료효긍정,교길서타빈연합순박유효솔상사,GC 방안치료조Ⅲ/Ⅳ도중성립세포감소증발생솔고,GP 방안치료조Ⅲ/Ⅳ도위장도반응발생솔고,재림상사용방면가이근거환자적특점선택구체적치료방안。
Objective:To investigate the resPonse and toxicity of the gemcitabine Plus carboPlatin(GC)and gem-citabine Plus cisPlatin(GP)in Pretreated metastatic triPle - negative breast cancer(TNBC)Patients. Methods:A to-tal of 57 Patients were divided into two grouPs:GC grouP(29 Patients)and GP grouP(28 Patients). The resPonse,tox-icity were comPared. Results:The resPonse rate(RR)were 62. 1% and 57. 1% in the GC and GP grouP resPectively, there was no significant difference between them(P ﹥ 0. 05). The median time to Progression(TTP)and median sur-vival time were 5. 4 months,8. 3 months in GC grouP,and 5. 6 months,9. 0 months in GP grouP,there was no signifi-cant difference between them(P ﹥ 0. 05). Grade Ⅲ - Ⅳ nausea/ vomiting in GC grouP was lower than that in GP grouP(6. 9% vs 28. 6% ,P ﹤ 0. 05). Grade Ⅲ - Ⅳ leukoPenia in GC grouP was higher than that in GP grouP (31. 0% vs 14. 3% ,P ﹤ 0. 05). Conclusion:The GC regimen is similar to GP regimen,but grade Ⅲ - Ⅳ leukoPenia in GC grouP was higher than that in GP grouP,grade Ⅲ - Ⅳ nausea/ vomiting in GC grouP was lower than that in GP grouP.